Steve Freedman is faculty for Harvard Catalyst’s Postgraduate Education. He is director of the Pancreas Center at Beth Israel Deaconess Medical Center (BIDMC), as well as chief of the Division of Translational Research, director of clinical research, and professor of medicine at Harvard Medical School (HMS). He plays a leadership role in clinical/translational research, both at BIDMC and HMS through his prior role as the associate dean for clinical and translational research and co-director of Harvard Catalyst. He developed the Grant Review and Support Program (GRASP) in collaboration with Harvard Catalyst in 2011 and has been the program director since then.
Freedman’s expertise is in exocrine pancreatic disease, focusing on pancreatitis and cystic fibrosis in adults and children. He is an internationally recognized leader in these areas, with an extensive research program that encompasses both basic science as well as clinical trials of new therapies for these diseases. His collaborative work with Camilia Martin in the Department of Neonatology at BIDMC has led to new insights into how fatty acids and nutrition may predispose preterm infants to chronic lung disease and infection. Freedman has also focused on healthcare delivery reform that addresses structuring the doctor-patient encounter to build informed partnerships that can lead to sustained improvements in health outcomes. He earned his PhD from Yale University School of Medicine and MD at the University of Connecticut. He completed his residency and fellowship in gastroenterology at BIDMC.